Dr. Reddy's Laboratories Ltd.

BSE

Price on BSE 10 Aug,13:56 LIVE

1,166.00

-6.00

(-0.51%)

Volume :
167,700.00

Prev Close :
1,172.00

Day's H/L (Rs.) :
1,178.35 - 1,163.25

52wk H/L (Rs.) :
1,414.40 - 1,080.05

Mkt Cap (Rs. Cr) :
97,326.03

NSE

Price on NSE 10 Aug,14:52 LIVE

1,161.40

-10.60

(-0.90%)

Volume :
1,561,926.00

Prev Close :
1,172.00

Day's H/L (Rs.) :
1,178.80 - 1,159.90

52wk H/L (Rs.) :
1,414.90 - 1,101.00

Mkt Cap (Rs. Cr) :
0.00

Market News

Dr Reddy's Labs plunges 69% to Rs 443 crore, hit by lenalidomide exit and semaglutide issues
Rediff.com 23 Jul 2026

Q1 Earnings, West Asia Tensions, Crude Oil to Drive Market Movement This Week
Rediff.com 19 Jul 2026

Indian Pharma Bets Beyond US Generics
Rediff.com 26 Jun 2026

Report Card - Dr. Reddy's Laboratories Ltd.

PE Ratios

30.39

EPS (Rs.)

38.56

Sales (Rs. Cr)

5,136.60

Face Value (Rs.)

Net Profit Margin(%)

15.68

Last Bonus

1:1

Last Dividend(%)

800

Return on Average Equity

10.26

News for Dr. Reddy's Laboratories Ltd.

Dr Reddy''s Launches Generic Sugammadex Injection in US

Dr Reddy''s launches generic Sugammadex injection in the US, offering an affordable alternative to Bridion for reversing muscle relaxants during surgery.

Aug 04, 2026 13:33

Dr Reddy''s shares tumble 9% post-Q1 earnings, hit 52-week low

Dr Reddy''s shares plunged nearly 9% to a 52-week low after Q1 net profit fell 69.2%. Semaglutide API issues and generics revenue dip cited.

Jul 23, 2026 11:00

Dr Reddy''s CEO: US Tariffs Will Hike Drug Prices

Dr Reddy''s CEO Erez Israeli warns US tariffs on generic medicines will lead to higher drug prices. India, a major exporter, will be impacted by Trump''s plan.

Jul 22, 2026 19:03

Dr Reddy''s Q1 Profit Plunges 69.2% Amid Semaglutide Issue

Dr Reddy''s Q1 net profit fell 69.2% to Rs 434.8 cr, impacted by semaglutide ingredient provisions & North America generics dip. Revenue also declined.

Jul 22, 2026 17:19

Dr Reddy''s Foundation Scales Soil Testing to 1 Lakh Samples

Dr Reddy''s Foundation''s Hyderabad soil testing lab aims for 1 lakh samples by Rabi season, addressing soil health concerns & promoting regenerative agriculture for farmers.

Jul 19, 2026 14:14

More News for Dr. Reddy's Laboratories Ltd. »

News for Pharmaceuticals and health care

Indian IPOs FY26: Rs 1.9 Lakh Cr Raised, Listing Gains Cool

Indian firms raised Rs 1.9 lakh crore through 360+ IPOs in FY26. Despite robust fundraising, listing gains cooled as investors became more selective.

Aug 10, 2026 14:42

AstraZeneca Pharma India Q1 Profit Drops 32% to Rs 37.93 Cr

AstraZeneca Pharma India Ltd reports a 32% drop in Q1 profit to Rs 37.93 crore due to higher expenses, despite revenue growth. Get the full financial results.

Aug 10, 2026 14:30

Amara Raja Energy & Mobility Q1 PAT Jumps 16% to Rs 191 Cr

Amara Raja Energy & Mobility reports 16% Q1 PAT increase to Rs 191 Cr. Revenue hits Rs 4,214 Cr, driven by strong lead acid battery & new energy business growth.

Aug 10, 2026 14:20

Singapore Airlines Appoints Aswin K as India General Manager

Singapore Airlines names Aswin K as its new General Manager for India, overseeing operations and growth strategy in this key market. He brings 12+ years of experience.

Aug 10, 2026 14:15

Sarla Aviation Gets DGCA Design Approval for Electric Air Taxi

Sarla Aviation secures DGCA Design Organisation Approval (DOA) for its electric air taxi (eVTOL) development. This milestone enables commercial production and boosts indigenous aerospace in India.

Aug 10, 2026 14:04

More News »

Top News